Dr. Gary Barker
Partner and Co-Founder, EYE ASSOCIATES OF WINTER PARK
Member of the Healthcare Council
Council Member Biography
Gary Barker, OD, FAAO, is a Partner and Co-Founder of the four-doctor group practice Eye Associates of Winter Park in Winter Park, Florida. The practice is full-scope, treating infants to seniors. The practice demographic shows a normal age distribution with the average patient age of 35, and average yearly income of $60,000. Dr. Barker is the Past-President of the Florida Optometric Association, where he remains active in legislative affairs. Clinically, Dr. Barker has participated in numerous Phase III FDA studies of new contact lenses and contact lens solutions. He is familiar with all types of contact lenses and contact lens care systems, and stays aware of trends in the contact lens market. Dr. Barker is also familiar the trends in eye care as well as with the latest technologies used in the diagnosis and treatment of eye conditions. He diagnoses and treats eye disease, including glaucoma, and is knowledgeable in the latest ophthalmic pharmaceuticals as well as nutraceuticals. Dr. Barker is well-respected among his colleagues and is known for his ability to speak his mind on many subjects. (This is me - Update Profile)
Employment History
- 1985 - Unspecified
- Partner and Co-Founder, EYE ASSOCIATES OF WINTER PARK
- 1983 - 1984
- Examiner, Early Treatment of Diabetic Retinopathy , UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
GLG NewsSM Analyses by Gary Barker
GLG News is now G+ Insights
-
G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.
-
Welcome addition to our armament, but overuse potential?
July 14, 2009
Bausch and Lomb (BOL) Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye') | www.lifescience-online.com
Potential for overuse and more drug-resistant bacteria
-
Will J&J's new one-day lens effect the one-day market?
November 17, 2008
Johnson & Johnson Vision Care Announces First Daily Disposable Silicone Hydrogel at BCLA | www.cltoday.com
New innovations in the contact lens market are needed to boost growth in sales, especially in the one-day lens market.
-
Is LASIK the issue or is choosing the right refractive surgery for the right patient the real issue?
May 7, 2008
LASIK Worries? Some May See Better with Alternatives | www.washingtonpost.com
I welcome the FDA investigation of LASIK, as thousands of patients are undergoing the elective cosmetic procedure, with some achieving less than optimum results. Will the study show that LASIK is not safe, or will it show that LASIK is not the real issue, rather that patient selection is the true issue?
-
Injectable glaucoma drug vs. patient compliance
April 15, 2008
Injectable glaucoma drug shown to reduce IOP in clinical study | www.osnsupersite.com
Any new efficacious glaucoma treatment is welcome and needed, but patient compliance remains a factor. A single injection treatment that provides IOP reduction for 3 months would greatly improve success in IOP control. I would, however, like to see a lower target pressure set for the study.
-
April 15, 2008
Novartis to buy Nestle's Alcon stakes for $39 billion | www.wtnzfox43.com
The purchase of a controlling interest in Alcon by Novartis is a brilliant move by Novartis. To bring the leading contact lens disinfectant together with Ciba's contact lenses is a wonderful marketing opportunity for Ciba.
GLG Study Groups with Gary Barker(?)
| Study Group Name | No. Members |
|---|---|
| Optometrists | 380 |
| Optometrists (US) | 291 |
| Silicone Hydrogel and Bausch and Lomb Contact Lens Prescribers: Ophthalmologists and Optometrists (US) | 187 |
| Contact Lens Sellers (US) | 49 |
GLG Live Meetings with Gary Barker(?)
Gary Barker has not participated in any GLG Live Meetings.
Gerson Lehrman Group, Inc. connects communities with knowledge through two distinct, yet complementary offerings: GLG Research and G+.